Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
Oncoscience|October 27, 2015
JAK-STAT in lymphoproliferative disordersRaul Rabadan, Giorgio Inghirami
Current Opinion in Pharmacology|June 9, 2015
Anaplastic lymphoma kinase inhibitorsRamona Crescenzo, Giorgio Inghirami
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2025
A sophisticated approach to targeting TERT activity in DLBCLGiorgio Inghirami, Leandro Cerchietti
Current Opinion in Hematology|June 9, 2017
Patient-derived tumor xenografts of lymphoproliferative disorders: are they surrogates for the human disease?Marco Pizzi, Giorgio Inghirami
Seminars in Diagnostic Pathology|August 20, 2011
Anaplastic large-cell lymphomaGiorgio Inghirami, Stefano A Pileri,
Blood|May 21, 2026
Can we target CTCL clonal evolution and improve outcomes?Paul Dylan Barone, Giorgio Inghirami
Hematological Oncology|May 26, 2017
Are we ready to take full advantage of patient-derived tumor xenograft models?Peter W Kyriakides, Giorgio Inghirami
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2006
STAT3: a multifaceted oncogeneDavid E Levy, Giorgio Inghirami
Annual Review of Pathology|February 8, 2018
Pathogenesis of Peripheral T Cell LymphomaMarco Pizzi, Elizabeth Margolskee, Giorgio Inghirami
Advances in Experimental Medicine and Biology|August 19, 2007
Identification and validation of the anaplastic large cell lymphoma signatureRoberto Piva, Elisa Pellegrino, Giorgio Inghirami
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
Oncoscience|October 27, 2015
JAK-STAT in lymphoproliferative disordersRaul Rabadan, Giorgio Inghirami
Current Opinion in Pharmacology|June 9, 2015
Anaplastic lymphoma kinase inhibitorsRamona Crescenzo, Giorgio Inghirami
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2025
A sophisticated approach to targeting TERT activity in DLBCLGiorgio Inghirami, Leandro Cerchietti
Current Opinion in Hematology|June 9, 2017
Patient-derived tumor xenografts of lymphoproliferative disorders: are they surrogates for the human disease?Marco Pizzi, Giorgio Inghirami
Seminars in Diagnostic Pathology|August 20, 2011
Anaplastic large-cell lymphomaGiorgio Inghirami, Stefano A Pileri,
Blood|May 21, 2026
Can we target CTCL clonal evolution and improve outcomes?Paul Dylan Barone, Giorgio Inghirami
Hematological Oncology|May 26, 2017
Are we ready to take full advantage of patient-derived tumor xenograft models?Peter W Kyriakides, Giorgio Inghirami
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2006
STAT3: a multifaceted oncogeneDavid E Levy, Giorgio Inghirami
Annual Review of Pathology|February 8, 2018
Pathogenesis of Peripheral T Cell LymphomaMarco Pizzi, Elizabeth Margolskee, Giorgio Inghirami
Advances in Experimental Medicine and Biology|August 19, 2007
Identification and validation of the anaplastic large cell lymphoma signatureRoberto Piva, Elisa Pellegrino, Giorgio Inghirami
Pageof 24